Alexandria Real Estate Equities
ARE
#2143
Rank
A$13.38 B
Marketcap
A$76.83
Share price
0.30%
Change (1 day)
-32.10%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2026 (TTM): -A$0.95 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are A$2.85 Billion. In 2025 the company made an earning of -A$1.44 Billion a decrease over its 2024 earnings that were of A$1.00 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.95 Billion-34.09%
2025 -A$1.44 Billion-242.13%
2024 A$1.00 B96.11%
2023 A$0.51 B-53.56%
2022 A$1.10 B-3.96%
2021 A$1.15 B-20.26%
2020 A$1.44 B72.88%
2019 A$0.83 B3.11%
2018 A$0.81 B73.54%
2017 A$0.46 B464.88%
2016 A$82.83 M-77.32%
2015 A$0.36 B36.31%
2014 A$0.26 B-10.81%
2013 A$0.30 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$15.35 B-1,817.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$45.11 B-5,147.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$13.17 B-1,573.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$14.19 B-1,688.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.68 B-288.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.90 B-1,656.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.26 B-241.04%๐Ÿ‡บ๐Ÿ‡ธ USA